Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.530
-0.050 (-3.16%)
At close: Oct 30, 2026, 4:00 PM EDT
1.560
+0.030 (1.96%)
After-hours: Oct 30, 2026, 5:21 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $559.29 million as of October 30, 2026. Its market cap has decreased by 62.23% in one year.
Market Cap
559.29M
Enterprise Value
570.76M
1-Year Change
-62.23%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $559.29M, a decrease of -93.91%. That is a compound annual growth rate of -42.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 559.29M | -50.80% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 1.15B |
| Harrow | 1.12B |
| Collegium Pharmaceutical | 782.31M |
| Ironwood Pharmaceuticals | 598.17M |
| Aquestive Therapeutics | 507.07M |
| Alpha Teknova | 499.17M |
| Evolus | 496.70M |
| Kamada | 454.53M |